新鲜基3D打印壳聚糖小肠再生结构的制备及体内表征。

Parul Chaurasia, Richa Singh, Rishabh Rai Kaushik, Narayan Yadav, Sanjeev Kumar Mahto
{"title":"新鲜基3D打印壳聚糖小肠再生结构的制备及体内表征。","authors":"Parul Chaurasia, Richa Singh, Rishabh Rai Kaushik, Narayan Yadav, Sanjeev Kumar Mahto","doi":"10.1088/1748-605X/ade5e1","DOIUrl":null,"url":null,"abstract":"<p><p>This study demonstrates the implantation of a 3D-printed small intestine construct using chitosan bioink and freeform reversible embedding of suspended hydrogels (FRESH) bioprinting technology. The research addresses the significant clinical challenges posed by inflammatory bowel disease (IBD) and short bowel syndrome (SBS), which often require surgical interventions leading to substantial loss of small intestine (SI) surface area. High costs, side effects, and donor shortages limit traditional treatments such as total parenteral nutrition and small bowel transplantation. Therefore, developing an engineered artificial intestine represents a critical need. The study employed a natural biopolymer, i.e., chitosan, known for its biocompatibility and blood compatibility, as the primary material for the bioink. The 3D-bioprinted constructs were evaluated through mechanical characterization, blood biocompatibility tests, and antibacterial assays. The mechanical properties indicated the constructs' ability to withstand significant deformation, while the blood compatibility tests showed minimal hemolysis, supporting the material's suitability for implantation. Antibacterial tests revealed that the constructs could inhibit bacterial growth, reducing the risk of implant-associated infections. Following the implantation of the prepared constructs in rats, the post-implantation analysis indicated successful integration and biocompatibility with no significant adverse reactions. The biochemical parameters, like inflammatory markers, were found to be slightly higher than the normal range. All other parameters, like bilirubin and albumins, etc, were in the normal range. This study highlights the potential of 3D-bioprinted chitosan-based constructs in organ regeneration and presents a promising solution for treating SBS and IBD. The findings support further exploration of the fabricated 3D printed biocompatible materials for medical applications in regenerative medicine and tissue engineering.&#xD.</p>","PeriodicalId":72389,"journal":{"name":"Biomedical materials (Bristol, England)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fabrication and in vivo characterization of FRESH-based 3D printed chitosan construct for small intestine regeneration.\",\"authors\":\"Parul Chaurasia, Richa Singh, Rishabh Rai Kaushik, Narayan Yadav, Sanjeev Kumar Mahto\",\"doi\":\"10.1088/1748-605X/ade5e1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study demonstrates the implantation of a 3D-printed small intestine construct using chitosan bioink and freeform reversible embedding of suspended hydrogels (FRESH) bioprinting technology. The research addresses the significant clinical challenges posed by inflammatory bowel disease (IBD) and short bowel syndrome (SBS), which often require surgical interventions leading to substantial loss of small intestine (SI) surface area. High costs, side effects, and donor shortages limit traditional treatments such as total parenteral nutrition and small bowel transplantation. Therefore, developing an engineered artificial intestine represents a critical need. The study employed a natural biopolymer, i.e., chitosan, known for its biocompatibility and blood compatibility, as the primary material for the bioink. The 3D-bioprinted constructs were evaluated through mechanical characterization, blood biocompatibility tests, and antibacterial assays. The mechanical properties indicated the constructs' ability to withstand significant deformation, while the blood compatibility tests showed minimal hemolysis, supporting the material's suitability for implantation. Antibacterial tests revealed that the constructs could inhibit bacterial growth, reducing the risk of implant-associated infections. Following the implantation of the prepared constructs in rats, the post-implantation analysis indicated successful integration and biocompatibility with no significant adverse reactions. The biochemical parameters, like inflammatory markers, were found to be slightly higher than the normal range. All other parameters, like bilirubin and albumins, etc, were in the normal range. This study highlights the potential of 3D-bioprinted chitosan-based constructs in organ regeneration and presents a promising solution for treating SBS and IBD. The findings support further exploration of the fabricated 3D printed biocompatible materials for medical applications in regenerative medicine and tissue engineering.&#xD.</p>\",\"PeriodicalId\":72389,\"journal\":{\"name\":\"Biomedical materials (Bristol, England)\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedical materials (Bristol, England)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1088/1748-605X/ade5e1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical materials (Bristol, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1088/1748-605X/ade5e1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本研究展示了使用壳聚糖生物墨水和自由形态可逆悬浮水凝胶包埋(FRESH)生物打印技术植入3d打印小肠结构。该研究解决了炎症性肠病(IBD)和短肠综合征(SBS)带来的重大临床挑战,这两种疾病通常需要手术干预,导致小肠(SI)表面积的大量损失。高昂的费用、副作用和供体短缺限制了传统的治疗方法,如全肠外营养和小肠移植。因此,开发一种工程化的人工肠是一种迫切的需求。该研究采用了一种天然生物聚合物,即壳聚糖,以其生物相容性和血液相容性而闻名,作为生物链接的主要材料。通过机械特性、血液生物相容性测试和抗菌试验来评估3d生物打印构建物。机械性能表明该结构具有承受显著变形的能力,而血液相容性测试显示溶血最小,支持该材料适合植入。抗菌测试显示,这种结构可以抑制细菌生长,降低植入物相关感染的风险。将制备的构建体植入大鼠体内后,植入后分析表明其整合成功,生物相容性良好,无明显不良反应。炎症指标等生化指标略高于正常范围。其他指标如胆红素、白蛋白等均在正常范围内。这项研究强调了3d生物打印壳聚糖在器官再生中的潜力,并为治疗SBS和IBD提供了一个有希望的解决方案。这一发现为进一步探索3D打印生物相容性材料在再生医学和组织工程中的医学应用提供了支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Fabrication and in vivo characterization of FRESH-based 3D printed chitosan construct for small intestine regeneration.

This study demonstrates the implantation of a 3D-printed small intestine construct using chitosan bioink and freeform reversible embedding of suspended hydrogels (FRESH) bioprinting technology. The research addresses the significant clinical challenges posed by inflammatory bowel disease (IBD) and short bowel syndrome (SBS), which often require surgical interventions leading to substantial loss of small intestine (SI) surface area. High costs, side effects, and donor shortages limit traditional treatments such as total parenteral nutrition and small bowel transplantation. Therefore, developing an engineered artificial intestine represents a critical need. The study employed a natural biopolymer, i.e., chitosan, known for its biocompatibility and blood compatibility, as the primary material for the bioink. The 3D-bioprinted constructs were evaluated through mechanical characterization, blood biocompatibility tests, and antibacterial assays. The mechanical properties indicated the constructs' ability to withstand significant deformation, while the blood compatibility tests showed minimal hemolysis, supporting the material's suitability for implantation. Antibacterial tests revealed that the constructs could inhibit bacterial growth, reducing the risk of implant-associated infections. Following the implantation of the prepared constructs in rats, the post-implantation analysis indicated successful integration and biocompatibility with no significant adverse reactions. The biochemical parameters, like inflammatory markers, were found to be slightly higher than the normal range. All other parameters, like bilirubin and albumins, etc, were in the normal range. This study highlights the potential of 3D-bioprinted chitosan-based constructs in organ regeneration and presents a promising solution for treating SBS and IBD. The findings support further exploration of the fabricated 3D printed biocompatible materials for medical applications in regenerative medicine and tissue engineering. .

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信